Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Momentum
USChina Trade Talks Reemerge as Key Focus at APEC Summit
Expected Value Approach May Boost Predictive AI Returns Fraud Detection Illustrates
Humana Shares Decline as Medicare Advantage Rate Update Disappoints Market Expectations
Salesforce Receives Mixed Analyst Reviews Deutsche Bank Maintains Positive Outlook While Citi Adjusts Price Target
Bitcoin Beyond Speculation Institutional Adoption Reshapes Cryptos Role in Finance
ELV Q1 2026 Earnings Strong Earnings Beat Overshadowed by Stock Decline
Corteva Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency
MGPI Q1 2026 Earnings EPS Surges Past Estimates with 30872 Surprise
GENI Q1 2026 Earnings EPS Falls Short Yet Stock Surges 583 on Strategic Optimism
FOA Q1 2026 Earnings Strong EPS Surprise Amidst Uncertain Revenue Outlook
SOS Limited Q3 2018 Earnings Significant EPS Miss Highlights Operational Challenges
Aclarion Inc Warrants ACONW Edge Lower as Tight Trading Range Persists at 003
Nuveen Mortgage and Income Fund JLS Edges Higher as YieldSeekers Circle
Aramark ARMK Slips 072 as Traders Eye Key Support Zone
Simulations Plus SLP Surges 268 as Shares Approach 1569 Resistance Zone
Church Dwight CHD Holds Steady with Modest Gains as Defensive Appeal Endures
HP Exceeds Estimates on AI PC and Windows 11 Demand Shares Initially Surge
QuidelOrtho Q1 2026 Earnings EPS Misses Estimates by Wide Margin Yet Stock Rises
abrdn Healthcare Opportunities Fund THQ Gains 087 as Sector Rotates into Defensive Names
XPO Q1 2026 Earnings EPS Surges 14 Above Estimates Despite Modest Stock Decline
STAA Q1 2026 Earnings EPS Soars Past Estimates Stock Declines Despite Strong Beat
VTRS Q1 2026 Earnings Strong EPS Beat of 1517 Surprise Amid Stable Execution
Apartment Investment and Management Company AIV Q3 2024 Earnings FFO Miss Raises Questions Amid Portfolio Transition
Septerna Inc SEPN Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Market Response
Sangoma Technologies Q1 2026 Earnings EPS Miss Weighs on Shares as Losses Widen
Cytokinetics CYTK Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Progress Continues